Management of Constipation in Older Adults with Dementia
Start with polyethylene glycol (PEG) 17g daily as first-line pharmacological treatment, combined with non-pharmacological interventions including adequate hydration, optimized toileting routines, and environmental modifications. 1
Initial Assessment and Prevention
Before initiating treatment, perform a digital rectal examination to rule out fecal impaction, especially if diarrhea accompanies constipation (overflow around impaction) 2. Also rule out obstruction through physical exam and consider abdominal x-ray 2.
Key preventive measures specific to dementia patients:
- Ensure toilet access and privacy, particularly critical given mobility limitations common in dementia 1
- Optimize toileting routines: Educate caregivers to assist patients in attempting defecation at least twice daily, ideally 30 minutes after meals, straining no more than 5 minutes 1
- Adequate hydration: Low liquid consumption is the strongest predictor of constipation in dementia patients 3. Individualize fluid goals based on patient's ability to consume fluids
- Address pain management: Unrecognized pain (e.g., arthritis) can contribute to behavioral resistance to toileting 4
- Environmental modifications: Use dementia-friendly signage, contrasting toilet seats, grab bars, and appropriate positioning aids 5
Pharmacological Management Algorithm
First-Line Treatment
PEG (polyethylene glycol) 17g daily is the preferred initial laxative 1, 6:
- Excellent safety profile in elderly patients
- Does not require increased fluid intake like bulk-forming agents
- Avoid bulk-forming laxatives (psyllium, bran) in non-ambulatory dementia patients with low fluid intake due to mechanical obstruction risk 1
Second-Line Options
If inadequate response to PEG, add or switch to:
- Bisacodyl 10-15mg daily to three times daily
- Senna 2-3 tablets twice to three times daily
- Sodium picosulfate 6
- Goal: 1 non-forced bowel movement every 1-2 days 2
Alternative osmotic laxatives 7:
- Lactulose 30-60mL twice to four times daily
- Magnesium hydroxide 30-60mL daily to twice daily (use cautiously—monitor for hypermagnesemia in renal impairment) 1
Managing Fecal Impaction
When digital rectal exam confirms impaction 2, 1:
- Manual disimpaction following pre-medication with analgesic ± anxiolytic 2
- Glycerine suppository ± mineral oil retention enema 2
- Bisacodyl suppository (one rectally daily to twice daily) 2
- Isotonic saline enemas (preferred in older adults over sodium phosphate enemas) 1
- Tap water enema until clear if above measures fail 2
Contraindications for enemas: Thrombocytopenia, neutropenia, recent colorectal surgery, severe colitis, undiagnosed abdominal pain 1
Critical Medication Considerations
Review and discontinue constipating medications 2, 8:
- Anticholinergics (worsen both constipation and cognition)
- Benzodiazepines
- Opioids (if on opioids, consider methylnaltrexone 0.15mg/kg subcutaneously every other day) 2
- Use STOPP/START or Beers criteria for medication review 8
Avoid in dementia patients 1:
- Liquid paraffin (aspiration pneumonia risk, especially bed-bound or dysphagia)
- Bulk agents in non-ambulatory patients with low fluid intake
Non-Pharmacological Interventions
Bowel training and defecation posture significantly improve outcomes 9:
- Structured toileting schedule
- Appropriate positioning (small footstool to assist gravity and pressure) 1
- Privacy and comfort during defecation 1
Abdominal massage may reduce gastrointestinal symptoms and improve bowel efficiency 1, 10
Dietetic support 1:
- Manage decreased food intake (anorexia of aging, chewing difficulties)
- Adequate fiber only if patient has adequate fluid intake and mobility
- Consider dietitian consultation 5
Common Pitfalls to Avoid
- Do not increase dietary fiber without ensuring adequate fluid intake and mobility—this increases obstruction risk in dementia patients 1
- Do not overlook constipation as a contributor to behavioral and psychiatric symptoms of dementia 9
- Do not assume patients will report symptoms—proactively assess, as dementia patients commonly ignore or cannot communicate constipation 3, 11
- Do not use magnesium salts without monitoring renal function 1
- Address caregiver education gaps—caregivers may not understand the link between dementia and bowel symptoms 4
Monitoring and Reassessment
- Monitor for adequate symptom management and quality of life 2
- Reassess for impaction or obstruction if treatment fails 2
- Regular monitoring if patient on diuretics or cardiac glycosides (dehydration and electrolyte imbalance risk) 1
- Implement maintenance bowel regimen after resolving impaction to prevent recurrence 1